2024 Annual Meeting | C73 - PFO Closure and LAA Closure: The Difficult Questions

��ɫ��

2024 Annual Meeting | C73 - PFO Closure and LAA Closure: The Difficult Questions

Date Monday 04/15/24

Time 11:15 AM - 12:15 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Saurav Das, MD

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Participants whould be able to list indications for PFO closure and LAA closure based on the most recent evidence, list the potential complications of these procedures, and weigh the risks and benefits to identify the right patients needing the procedure.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Recommended Audience Fellow, Resident, Other, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
11:15 AM - 11:20 AM MDT	Introduction	PFO Closure and LAA Closure: The Difficult Questions Saurav Das, MD
11:20 AM - 11:35 AM MDT	Speaker	PFO Closure in Stroke Patients: Review of Evidence Larry B. Goldstein, MD, FAHA, FAAN
11:35 AM - 11:50 AM MDT	Speaker	LAA Closure in Stroke Patients: Review of Evidence Andrew Leventhal
11:50 AM - 12:15 PM MDT	Speaker	PFO Closure and LAA Closure: A Case-based Discussion Saurav Das, MD

Faculty Disclosures
Saurav Das, MD	Dr. Das has nothing to disclose.
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Andrew Leventhal	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��